Alicia Kang

539 total citations
7 papers, 393 citations indexed

About

Alicia Kang is a scholar working on Molecular Biology, Infectious Diseases and Surgery. According to data from OpenAlex, Alicia Kang has authored 7 papers receiving a total of 393 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 3 papers in Infectious Diseases and 2 papers in Surgery. Recurrent topics in Alicia Kang's work include Gut microbiota and health (4 papers), SARS-CoV-2 and COVID-19 Research (2 papers) and Microscopic Colitis (2 papers). Alicia Kang is often cited by papers focused on Gut microbiota and health (4 papers), SARS-CoV-2 and COVID-19 Research (2 papers) and Microscopic Colitis (2 papers). Alicia Kang collaborates with scholars based in Australia and Singapore. Alicia Kang's co-authors include Sumaira Z. Hasnain, Ran Wang, Kuan Yau Wong, Yonghua Sheng, Lydia Murray, Jakob Begun, Graham Magor, Hui Tong, Andrew C. Perkins and Timothy H. Florin and has published in prestigious journals such as Nature Medicine, Gastroenterology and PLoS ONE.

In The Last Decade

Alicia Kang

7 papers receiving 391 citations

Peers

Alicia Kang
Comparison fields: 5 of 88
  • Molecular Biology 201
  • Physiology 95
  • Immunology 60
  • Epidemiology 55
  • Genetics 55
Replace Kimberley J. Lewis with:
Kimberley J. Lewis Canada
Chuyu Yun China
Andreas Rings Germany
Franziska A. Graef Canada
Shimin Liu China
Yutaka Sugi Japan
Haibo Chang China
Prithvi Raj United States
Rajiv Rana Germany
Kimberley J. Lewis Canada View profile →
Citations per field, relative to Alicia Kang
Alicia Kang · 1×
Citations per year, relative to Alicia Kang
Alicia Kang · 1×

Countries citing papers authored by Alicia Kang

Since Specialization
Citations

This map shows the geographic impact of Alicia Kang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alicia Kang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alicia Kang more than expected).

Fields of papers citing papers by Alicia Kang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alicia Kang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alicia Kang. The network helps show where Alicia Kang may publish in the future.

Co-authorship network of co-authors of Alicia Kang

This figure shows the co-authorship network connecting the top 25 collaborators of Alicia Kang. A scholar is included among the top collaborators of Alicia Kang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alicia Kang. Alicia Kang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
# Work Indexed citations
1 10
2 40
3
Treatment of ZAP-70 Mutant SKG Mice with Anti-IL-23 Antibody Alters Fecal Microbiota Composition and Prevents Outgrowth of Bacteria Associated with Susceptibility to Spondyloarthritis and Ileitis
1
4 270
5 2
6 39
7 31

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026